Sector valuations 10x Genomics, Inc.
Equities
TXG
US88025U1097
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.69 USD | -11.18% |
|
-20.18% | +2.33% |
| 02-20 | UBS Adjusts Price Target on 10x Genomics to $20 From $14, Maintains Neutral Rating | MT |
| 02-12 | 10x Genomics, Inc., Q4 2025 Earnings Call, Feb 12, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -17.22x | 2.69x | -0.1x | 2.69x | -17.68x | -12.83x | -.--% | 2.13B | |
| 24.56x | 2.47x | 4.14x | 2.65x | 10.65x | 15.05x | 0.97% | 12.84B | |
| -29.59x | -33.43x | 2.63x | 9.31x | -70.34x | -30.92x | -.--% | 11.44B | |
| 24.21x | 4.26x | -3.01x | 8.34x | 19.18x | 21.01x | 2.31% | 5.9B | |
| 21.91x | - | 4.32x | 3.39x | 9.66x | 10.55x | - | 5.07B | |
| 182.77x | 8.06x | -1.46x | 4.76x | 28.6x | 71.24x | -.--% | 5.38B | |
| 19.16x | 1.9x | -31.05x | 3.31x | 10.08x | 13.47x | 1.92% | 3.95B | |
| 17.23x | 2.18x | -7.14x | - | - | - | 3.39% | 2.88B | |
| 35.06x | 1.51x | 2.35x | - | - | - | 2.75% | 1.58B | |
| -9.34x | 0.91x | 0.03x | 3.82x | 12.96x | -17.64x | 1.17% | 1.36B | |
| 35.6x | 1.61x | -0.65x | - | - | - | - | 1.31B | |
| -1463x | 2.04x | 13.17x | - | - | - | - | 1.28B | |
| 23.67x | 4.07x | 0.54x | 5.96x | 16.75x | 18.84x | 1.21% | 1.22B | |
| 25.64x | 1.08x | 0.22x | - | - | - | 1.39% | 1.01B | |
| Average | -79.24x | -0.05x | -1.14x | 4.91x | 2.21x | 9.86x | 1.37% | 4.1B | |
| Weighted average by Cap. | -7.44x | -4.74x | -0.76x | 5.35x | -6.31x | 8.63x | 1.05% |
- Stock Market
- Equities
- TXG Stock
- Sector 10x Genomics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition